Wednesday, July 27, 2022 | 3:00 - 4:00pm EDT
On Wednesday, July 27, 2022, ALS TDI will be hosting a new ALS Town Hall discussion on tegoprubart. Tegoprubart is a potential treatment for ALS that was invented at ALS TDI and recently completed a phase 2a trial carried out by Eledon Pharmaceuticals. The discussion will be led by Eledon's Chief Executive Officer, Dr. David-Alexandre C. Gros, and President and Chief Scientific Officer, Dr. Steve Perrin, who will provide an overview of the drug mechanisms and the trial results.
More Town Halls
This text will be overwritten by jQuery